Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Resveratrol neuroprotection in a chronic mouse model of multiple sclerosis.
New-onset multiple sclerosis associated with adalimumab treatment in rheumatoid arthritis: a case report and literature review.
Induction of atypical EAE mediated by transgenic production of IL-6 in astrocytes in the absence of systemic IL-6.
Mesenchymal stem cells are mobilized from the bone marrow during inflammation.
Serum Biomarker gMS-Classifier2: Predicting Conversion to Clinically Definite Multiple Sclerosis.
[Neuropsychological assessment of patients with relapsing remitting multiple sclerosis prior to the use of immunomodulatory drugs].
Brainstem manifestations in neuromyelitis optica: a multicenter study of 258 patients.
[Impact of physical activity level on alexithymia and coping strategies in an over-40 multiple sclerosis population: A pilot study.]
The Use of Oral Disease-Modifying Therapies in Multiple Sclerosis.
Human Endogenous Retrovirus HERV-Fc1 Association with Multiple Sclerosis Susceptibility: A Meta-Analysis.
The essential role of t cells in multiple sclerosis: A reappraisal.
Spinal Cord Normalization in Multiple Sclerosis.
Biochemical markers of neurodegeneration in hereditary diffuse leucoencephalopathy with spheroids.
Tissue Transglutaminase in Marmoset Experimental Multiple Sclerosis: Discrepancy between White and Grey Matter.
Isolation of bacterial plasmid-related replication-associated circular DNA from a serum sample of a multiple sclerosis patient.
Massive exacerbation of multiple sclerosis after withdrawal and early restart of treatment with natalizumab.
Diagnosis of atypical forms of chronic inflammatory demyelinating polyradiculoneuropathy: a practical overview based on some case studies.
Monoclonal antibody therapies for the treatment of relapsing-remitting multiple sclerosis: differentiating mechanisms and clinical outcomes.
NDRG2 promoted secreted miR-375 in microvesicles shed from M1 microglia, which induced neuron damage.
Neuromuscular adaptations to long-term progressive resistance training translates to improved functional capacity for people with multiple sclerosis and is maintained at follow-up.
Utilization and patients' perceptions of the effectiveness of pain treatments in multiple sclerosis: A cross-sectional survey.
[Therapy adherence to immunomodulator treatment in patients with multiple sclerosis].
Association of SNPs of CD40 Gene with Multiple Sclerosis in Russians.
Case of Type 1 Diabetes Mellitus Following Interferon β-1a Treatment for Multiple Sclerosis.
Pregnancy and multiple sclerosis.

Pages